Sources Sought Novel and Enhanced Modalities for Optic Nerve Imaging

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SS-26-157

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN13

Additional Details
Set Aside

None

Place of Performance

Washington, District of Columbia, UNITED STATES

SourceSAM
Documents1
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a Sources Sought notice to identify potential industry partners with the capability to provide novel and enhanced modalities for optic nerve imaging. This market research effort, managed by the Health Science Futures Office (HSF), seeks to assess the breadth of industry interest, technical capabilities, and relevant experience in support of technology and research development activities focused on advanced optic nerve imaging. The primary objective of this procurement is to enable the development and application of innovative imaging technologies that can significantly advance the understanding, diagnosis, or treatment of optic nerve conditions. ARPA-H is particularly interested in solutions that represent a substantial improvement over existing modalities, with the potential to transform research and clinical practices related to optic nerve health. Key requirements for respondents include demonstrated expertise in research and development within the physical, engineering, and life sciences domains, as classified under NAICS code 541715 (excluding nanotechnology and biotechnology). Respondents are expected to provide information on their technical capabilities, prior experience with similar imaging technologies, and their capacity to support ARPA-H’s research and development objectives. The notice emphasizes the importance of novel approaches and enhanced imaging modalities, suggesting a focus on cutting-edge, potentially disruptive technologies. The place of performance for this effort is Washington, District of Columbia (DC), United States. The contracting entity is ARPA-H, a federal office within the National Institutes of Health. Interested parties are encouraged to review the attached sources sought request and follow the provided response instructions. This notice is for market research purposes only and does not constitute a solicitation for proposals or bids. There are no set-aside requirements or special considerations specified at this stage. The opportunity is open to all capable organizations that meet the outlined criteria. The notice remains active, with a response due date extended to July 10, 2026, at 5:00pm ET. Interested contractors should direct inquiries and submit responses to the primary contact, The THEA Team, via email at [email protected]. Additional details, including the official notice and attachments, can be accessed through the SAM.gov opportunity listing (Opportunity ID: c8ac5d2254924bd68cec89b01cdc34af). This opportunity is particularly relevant for organizations specializing in advanced imaging technologies, medical device research, and interdisciplinary life sciences innovation, seeking to collaborate with ARPA-H on transformative health research initiatives.